[China Cell: holding subsidiary product SCT650C receives ethical license for Australian phase Ia clinical trial] Science and Technology Innovation Board Daily reported on the 25th that the holding subsidiary product SCT650C has obtained the ethical license for Australian phase Ia clinical trial.